Novel Small Molecule Inhibitors of Vacuolar ATPase Pharmacy Academic Year 2023 Accepted Synthetic Medicinal Chemistry This project has an aim of creating highly selective small molecules that target unique functions of the vacuolar ATPase (V-ATPase) for application as antiviral and anticancer agents. Vincent Jo Davisson The student will independently design and synthesis a new series of candidate small molecule inhibitors of the V-ATPase. GPA > 2.95; current standing in the curriculum to graduate in Spring 2024; background in pharmaceutical sciences preferred. 4 15 (estimated)

This project is not currently accepting applications.